Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile
Frontiers in Microbiology · 10.07.2023 · 14
DOI: 10.3389/fmicb.2023.1204122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 10.07.2023. Verfasst von Hui Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Saccharomyces boulardii (S. boulardii) has shown clinical beneficial effect in inflammatory bowel diseases recently. However, the underlying mechanisms remain incompletely understood. The aim of present study was to tested whether S. boulardii targets gut microbiota to protect against the development of experimental colitis in mice.
Methods
Female C57BL/6 mice were gavaged with S. boulardii for 3 weeks before being challenged with dextran sulphate sodium to induce ulcerative colitis. Bodyweight, diarrhea severity, intestinal permeability, colonic histopathology, colonic inflammatory status, and epithelial cell death of mice were examined. The fecal microbiota and its metabolomic profiles were detected by 16S rDNA sequencing and UPLC-MS, respectively. Results and Discussion Supplementation with S. boulardii significantly prevented weight loss and colon shortening, lowered colonic inflammation, ameliorated epithelial injury, and enhanced the intestinal barrier integrity in colitis mice. By inhibiting the abundance of pathogenic bacteria and increasing the probiotics abundance, S. boulardii improved the microbial diversity and restored the microbiota dysbiosis. Moreover, it also modulated microbial metabolome and altered the relative contents of metabolites involving amino acids, lipids, energy and vitamin metabolisms. These yeast-driven shifts in gut flora and metabolites are were associated with each other and with the inflammation profile in colitis. Collectively, S. boulardii exerts protective effects on colitis in mice by reshaping gut microbiome and its metabolic profile, indicating it as a promising therapeutic avenue.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Nutriology, Oil Crops Research Institute, Chinese Academy of Agricultural Sciences, Wuhan, China.
- Hubei Key Laboratory of Lipid Chemistry and Nutrition, Oil Crops Research Institute, Chinese Academy of Agricultural Sciences, Wuhan, China.
- Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, H., Li, Y., Xu, J., Zuo, X., Yue, T., Xu, H., Sun, J., Wang, M., Ye, T., Yu, Y., & Yao, Y. (2023). Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1204122
Vancouver
Gao H, Li Y, Xu J, Zuo X, Yue T, Xu H, et al. Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1204122
BibTeX
@article{Gao2023,
author = {Gao, Hui and Li, Yinzheng and Xu, Jiqu and Zuo, Xuezhi and Yue, Tiantian and Xu, Huzi and Sun, Jie and Wang, Meng and Ye, Ting and Yu, Yan and Yao, Ying},
title = {Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1204122}
}
EUVIMED